68° F
May
21
Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Orexigen Therapeutics, Inc.

subscribe
Highlights

A collection of news and information related to Orexigen Therapeutics, Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-1 of 1
» View baltimoresun.com items only
    Mar 29, 2012 |Story| Reuters

  1. Obesity drugs need heart studies, U.S. advisers say

    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval.
    Reuters
    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval. An advisory panel to the U.S. Food and Drug Administration...

    Tags: Diseases and Illnesses, Abbott Laboratories, Drug Trafficking, Heart Disease, High Blood Pressure